NCT06018402

Brief Summary

Degenerative (de novo) scoliosis is the result of a long and multifactorial process that occurs through degenerative change in the aging population without a pre-existing spinal deformity. Pain is the most important symptom and the major difference from adolescent idiopathic scoliosis. Treatment is often complex and patient-specific. The first aim of our study is to evaluate the effectiveness of physical therapy on pain, disability and quality of life in patients with degenerative lumbar scoliosis and the second aim is to investigate whether erector spina plan block (ESPB) combined with physical therapy has an effect on the results.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 30, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

September 15, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 3, 2025

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

1.7 years

First QC Date

August 25, 2023

Last Update Submit

June 7, 2025

Conditions

Keywords

Degenerative lumbar scoliosisPhysical treatmentErector spinae plane blockLow back pain

Outcome Measures

Primary Outcomes (5)

  • NRS (Numeric Rating Scale)

    Pain Intensity Assessment ( 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    Day 0

  • NRS (Numeric Rating Scale)

    Pain Intensity Assessment ( 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    1 hour after injection

  • NRS (Numeric Rating Scale)

    Pain Intensity Assessment ( 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    1 week after physical treatment

  • NRS (Numeric Rating Scale)

    Pain Intensity Assessment ( 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    1 month after physical treatment

  • NRS (Numeric Rating Scale)

    Pain Intensity Assessment ( 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    3 month after physical treatment

Secondary Outcomes (8)

  • SRS-22

    Day 0

  • SRS-22

    1 week after physical treatment

  • SRS-22

    1 month after physical treatment

  • SRS-22

    3 month after physical treatment

  • Oswestry Disability Index

    Day 0

  • +3 more secondary outcomes

Study Arms (2)

physical therapy

ACTIVE COMPARATOR

The physical therapy program is planned as a total of 15 sessions in the lumbar region, each session consisting of TENS (50-100 Hz stimulation frequency, 200 µs pulse duration, intensity is increased as much as the patient could tolerate, 20 minutes in total), hotpack (to be placed on the painful area, 20 minutes), US (1 mHz frequency, 10 minutes, 1.5 watt/cm2 intensity)

Other: physical therapy

physical therapy + espb

ACTIVE COMPARATOR

same physical therapy program, in addition Ultrasound-guided lumbar ESPB is performed using an in-line cephalic approach, and after contacting the corner of the L3 transverse process, a small dose of saline is injected into the fascial space between the L3 transverse process and the erector spinae muscles to "lift off" the fascia. After verification, a mixture of 20 mL of 1% lidocaine and 3 mg betamethasone is administered for unilateral injection. The procedure is performed bilaterally.

Other: physical therapy + espb

Interventions

The physical therapy program is planned as a total of 15 sessions in the lumbar region, each session consisting of TENS (50-100 Hz stimulation frequency, 200 µs pulse duration, intensity is increased as much as the patient could tolerate, 20 minutes in total), hotpack (to be placed on the painful area, 20 minutes), US (1 mHz frequency, 10 minutes, 1.5 watt/cm2 intensity).

physical therapy

the same physical therapy program, in addition Ultrasound-guided lumbar ESPB is performed using an in-line cephalic approach, and after contacting the corner of the L3 transverse process, a small dose of saline is injected into the fascial space between the L3 transverse process and the erector spinae muscles to "lift off" the fascia. After verification, a mixture of 20 mL of 1% lidocaine and 3 mg betamethasone is administered for unilateral injection. The procedure is performed bilaterally.

physical therapy + espb

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being 60 years or older
  • Having a scoliosis of 10 degrees or more in the lumbar region according to the measurement made with the cobb method
  • Having pain in the axial waist or radiating from the waist to the leg
  • Pain that persists for at least 3 months
  • NRS \> 4

You may not qualify if:

  • Systemic or local infection at the injection site
  • Past or current history of malignant disease
  • Presence of neurological or orthopedic disease
  • Presence of uncontrolled hypertension, diabetes mellitus
  • Presence of severe heart failure
  • Presence of bleeding diathesis
  • Anticoagulant use
  • Lidocaine allergy
  • Psychiatric disorder or mental problem
  • inflammatory spine pain
  • Severe osteoporosis / previous vertebral fracture
  • Body mass index \>35
  • Having had previous surgery on the lumbar region
  • Injection was applied to the waist region within 6 months or physical have been treated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Farih Sultan Mehmet Training and Research Hospital

Istanbul, 34752, Turkey (Türkiye)

Location

Fatih Sultan Mehmet Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (6)

  • Graham RB, Sugrue PA, Koski TR. Adult Degenerative Scoliosis. Clin Spine Surg. 2016 Apr;29(3):95-107. doi: 10.1097/BSD.0000000000000367.

    PMID: 26945131BACKGROUND
  • Ploumis A, Transfledt EE, Denis F. Degenerative lumbar scoliosis associated with spinal stenosis. Spine J. 2007 Jul-Aug;7(4):428-36. doi: 10.1016/j.spinee.2006.07.015. Epub 2007 Feb 28.

    PMID: 17630141BACKGROUND
  • Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.

    PMID: 27501016BACKGROUND
  • Ahiskalioglu A, Alici HA, Ciftci B, Celik M, Karaca O. Continuous ultrasound guided erector spinae plane block for the management of chronic pain. Anaesth Crit Care Pain Med. 2019 Aug;38(4):395-396. doi: 10.1016/j.accpm.2017.11.014. Epub 2017 Dec 15. No abstract available.

    PMID: 29253539BACKGROUND
  • Akyuz ME, Firidin MN. Bilateral ultrasound-guided erector spinae plane block for postoperative persistent low back pain in lumbar disc surgery. Eur Spine J. 2022 Jul;31(7):1873-1878. doi: 10.1007/s00586-022-07212-z. Epub 2022 Apr 14.

    PMID: 35420380BACKGROUND
  • Durmus IE, Surucu S, Muz A, Takmaz SA. The effectiveness of erector spinae plane block in patients with chronic low back pain. Eur Rev Med Pharmacol Sci. 2023 Jan;27(1):138-143. doi: 10.26355/eurrev_202301_30864.

    PMID: 36647861BACKGROUND

MeSH Terms

Conditions

Low Back Pain

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Ozge Gulsum Illeez

    Fatih Sultan Mehmet Taining and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, Randomised, Clinical Study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 25, 2023

First Posted

August 30, 2023

Study Start

September 15, 2023

Primary Completion

May 15, 2025

Study Completion

June 3, 2025

Last Updated

June 11, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations